As of 2026-04-13, the Relative Valuation of Insmed Inc (INSM) is (78.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 151.14 USD, the upside of Insmed Inc based on Relative Valuation is -151.9%.
The range of the Relative Valuation is (60.54) - (90.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 15.3x | 10.7x |
| Forward P/E multiples | 10.2x - 21.2x | 15.8x |
| Fair Price | (60.54) - (90.75) | (78.48) |
| Upside | -140.1% - -160.0% | -151.9% |
| Date | P/E |
| 2026-04-13 | -25.52 |
| 2026-04-10 | -26.14 |
| 2026-04-09 | -26.94 |
| 2026-04-08 | -27.04 |
| 2026-04-07 | -27.52 |
| 2026-04-06 | -27.66 |
| 2026-04-02 | -27.42 |
| 2026-04-01 | -27.83 |
| 2026-03-31 | -27.61 |
| 2026-03-30 | -25.88 |
| 2026-03-27 | -24.53 |
| 2026-03-26 | -24.92 |
| 2026-03-25 | -25.04 |
| 2026-03-24 | -23.49 |
| 2026-03-23 | -24.31 |
| 2026-03-20 | -22.96 |
| 2026-03-19 | -24.31 |
| 2026-03-18 | -24.09 |
| 2026-03-17 | -24.30 |
| 2026-03-16 | -24.41 |
| 2026-03-13 | -23.55 |
| 2026-03-12 | -23.55 |
| 2026-03-11 | -23.53 |
| 2026-03-10 | -24.29 |
| 2026-03-09 | -24.16 |
| 2026-03-06 | -23.66 |
| 2026-03-05 | -24.24 |
| 2026-03-04 | -25.30 |
| 2026-03-03 | -24.82 |
| 2026-03-02 | -24.70 |
| 2026-02-27 | -25.21 |
| 2026-02-26 | -25.32 |
| 2026-02-25 | -25.09 |
| 2026-02-24 | -26.78 |
| 2026-02-23 | -26.85 |
| 2026-02-20 | -27.84 |
| 2026-02-19 | -27.18 |
| 2026-02-18 | -25.51 |
| 2026-02-17 | -25.41 |
| 2026-02-13 | -25.11 |
| 2026-02-12 | -24.68 |
| 2026-02-11 | -25.06 |
| 2026-02-10 | -25.08 |
| 2026-02-09 | -25.25 |
| 2026-02-06 | -25.30 |
| 2026-02-05 | -25.50 |
| 2026-02-04 | -25.74 |
| 2026-02-03 | -26.53 |
| 2026-02-02 | -26.00 |
| 2026-01-30 | -26.48 |